ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
TRY2.66bn
Enterprise Value
TRY2.32bn
Revenue
TRY238.21m

Annual balance sheet for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Interim Report	ARS	ARS	Interim Report
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.36	135	514	654	414
Net Total Accounts Receivable
Net Total Receivables	10.7	115	105	105	125
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.8	316	708	1,093	840
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.08	64.5	129	448	531
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	34.2	396	860	1,650	1,557
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.82	54.9	28	26.1	53.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	18	85.9	93	143	161
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.2	310	767	1,508	1,396
Total Liabilities & Shareholders' Equity	34.2	396	860	1,650	1,557
Total Common Shares Outstanding